2021 presentations - Practical Recommendations in Immuno and Molecular Oncology (PRIMO)

2021 Presentations

Hematologic Malignancies - Julie Vose / Sagar Lonial
Update on Novel Therapies for Non-Hodgkin Lymphoma
Relapsed and Refractory Multiple Myeloma: Choosing the Right Treatment
Sequencing of Therapies for Chronic Lymphocytic Leukemia
Acute Myelogenous Leukemia: Treatment Options
Multidisciplinary Oncology Team - Jorge J. Garcia
Physician Assistant Presentation: Immunotherapy Side Effects Management
Pharmacist Presentation: Biosimilars in Hematology Oncology: Breaking Barriers
Nurse Practitioner Presentation: Management of Patients at Risk for Hereditary Cancers
Gastrointestinal Malignancies - Rachna T. Shroff
Changing the Landscape in Pancreatic/Biliary Cancers
The Targeted and Immunotherapy Revolution in Upper GI Malignancies

Melanoma, Skin Cancers, RCC – Shane Morita
Melanoma: Keeping Up With the Data
Sarcoma: Where are We Making Progress?
Medical Therapy for Head and Neck Cancers: Current Status

GU Cancers - Donald Trump
Bladder Cancer: Sequencing Therapeutic Choices
RCC: A Surfeit of Riches – What’s a Clinician to Do?
Impact of COVID-19 on Cancer Care

Immunotherapy for Advanced NSCLC.
Matching Drugs to Targets in NSCLC
Therapeutic Advances in SCLC;

Breast Cancer - Hope S. Rugo, MD
New Directions in the Treatment of ER+ Breast Cancer
Updates in the Treatment of HER2+ Breast Cancer
Triple Negative Breast Cancer: Immunotherapy and Novel Agents
Breast Cancer - Hope S. Rugo, MD
Managing the Toxicity of Endocrine Therapy: Diet, Exercise, Sexual Health
Genomics to Guide Therapy in Early and Late Stage Breast Cancer
Metastatic Survivorship Care
SITC on Practical Recommendations Including Reimbursement Issues
Other Women's Cancers - Hope S. Rugo, MD
Ovarian Cancer: PARP, Bevacizumab, Immunotherapy
Cervical and Uterine Cancer Updates